Hong Kong’s new chapter

Introducing a biotech chapter to the Hong Kong stock exchange fills a massive void in the region’s innovation ecosystem, but won’t come without risks.

It promises to create a long sought public capital market for biotechs in China and the Asia-Pacific region, which have been shut out by revenue and profit thresholds...